Multiple Functional Gastrointestinal Disorders Linked to Gastroesophageal Reflux and Somatization: A Population-based Study

Overview

Journal Neurogastroenterol Motil

Specialties Gastroenterology
Neurology

Date 2017 Mar 4

PMID 28256048

Citations 16

Authors

R S Choung

G Richard Locke 3rd

C D Schleck

A R Zinsmeister

N J Talley

Affiliations

Soon will be listed here.

Abstract

Background: It is unknown why functional gastrointestinal disorders (FGIDs) overlap and limited information exists on risk factors for those with overlap. Our aim was to estimate the prevalence of combinations of FGIDs including reflux (FGIDs-gastroesophageal reflux [GER]), and evaluate potential risk factors for people with multiple disorders in a representative US community.

Methods: A population-based study was conducted by mailing a valid GI symptom questionnaire to an age- and gender-stratified random sample of residents of Olmsted County, MN. Rome III definitions were used to identify people with FGIDs, and GER was defined by weekly or more frequent heartburn or acid regurgitation. The prevalence of people meeting multiple symptom complexes was estimated. Moreover, potential risk factors for people with multiple disorders were evaluated.

Key Results: A total of 3548 people provided data for each of the necessary symptom questions (mean age: 61±16 years, 54% female). Among these 3548 subjects, 2009 (57%) had no FGIDs-GER, 906 (26%) had a pure FGID-GER, 372 (10%) had 2 FGIDs-GER, and 261 (7%) had 3 or more FGIDs-GER. Somatization as assessed by a higher Somatic Symptom Checklist score (OR=3.3, 95% CI [2.7,4.1]) was associated with an increased odds for those with 3 or more FGIDs-GER compared to subjects with a pure FGID-GER adjusting for age and gender.

Conclusions And Inferences: Symptom complex overlap is common rather than rare in the community. GER is an integral symptom complex associated with both upper and lower FGIDs. Somatization is a strong risk factor for multiple FGIDs.

Citing Articles

Symptom profiles compatible with disorders of gut-brain interaction (DGBI) in organic gastrointestinal diseases: A global population-based study.

van Gils T, Hreinsson J, Tornblom H, Tack J, Bangdiwala S, Palsson O United European Gastroenterol J. 2024; 12(7):834-847.

PMID: 38975964 PMC: 11497654. DOI: 10.1002/ueg2.12617.

Abdominal Pain of Functional Gastrointestinal Disorders in Dietary Diversity Patterns and Its Determinants among Healthy Adults in Jimma City, Southwest Ethiopia.

Zawdie B, Abate K, Tamiru D, Belachew T Ethiop J Health Sci. 2024; 33(6):1027-1038.

PMID: 38784486 PMC: 11111273. DOI: 10.4314/ejhs.v33i6.13.

Assessment and treatment of reflux-like symptoms in the community: a multidisciplinary perspective.

Kahrilas P, Anastasiou F, Barrett K, Beh L, Chinzon D, Doerfler B Br J Gen Pract. 2024; 74(742):232-235.

PMID: 38664044 PMC: 11060810. DOI: 10.3399/bjgp24X737349.

The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease.

Wasko-Czopnik D, Wiatrak B Prz Gastroenterol. 2024; 19(1):60-66.

PMID: 38571541 PMC: 10985762. DOI: 10.5114/pg.2023.133915.

Understanding and managing patients with overlapping disorders of gut-brain interaction.

Balsiger L, Carbone F, Raymenants K, Scarpellini E, Tack J Lancet Gastroenterol Hepatol. 2023; 8(4):383-390.

PMID: 36702144 PMC: 7615746. DOI: 10.1016/S2468-1253(22)00435-6.

References

Tack J, Talley N, Camilleri M, Holtmann G, Hu P, Malagelada J . Functional gastroduodenal disorders. Gastroenterology. 2006; 130(5):1466-79. DOI: 10.1053/j.gastro.2005.11.059. View

Choung R, Locke G, Schleck C, Zinsmeister A, Talley N . Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013; 25(5):413-9, e298. PMC: 3631281. DOI: 10.1111/nmo.12082. View

St Sauver J, Grossardt B, Yawn B, Melton 3rd L, Rocca W . Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol. 2011; 173(9):1059-68. PMC: 3105274. DOI: 10.1093/aje/kwq482. View

Piche T, Bruley des Varannes S, Sacher-Huvelin S, Holst J, Cuber J, Paul Galmiche J . Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003; 124(4):894-902. DOI: 10.1053/gast.2003.50159. View

Spiller R . Postinfectious functional dyspepsia and postinfectious irritable bowel syndrome: different symptoms but similar risk factors. Gastroenterology. 2010; 138(5):1660-3. DOI: 10.1053/j.gastro.2010.03.024. View

Aaron L, Buchwald D . A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001; 134(9 Pt 2):868-81. DOI: 10.7326/0003-4819-134-9_part_2-200105011-00011. View

Larsson M, Tillisch K, Craig A, Engstrom M, Labus J, Naliboff B . Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology. 2011; 142(3):463-472.e3. PMC: 3288538. DOI: 10.1053/j.gastro.2011.11.022. View

Chey W, Nojkov B, Rubenstein J, Dobhan R, Greenson J, Cash B . The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010; 105(4):859-65. PMC: 2887227. DOI: 10.1038/ajg.2010.55. View

Kurland L, Molgaard C . The patient record in epidemiology. Sci Am. 1981; 245(4):54-63. DOI: 10.1038/scientificamerican1081-54. View

10.

Van Oudenhove L, Vandenberghe J, Vos R, Fischler B, Demyttenaere K, Tack J . Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med. 2011; 73(8):648-55. DOI: 10.1097/PSY.0b013e31822f32bf. View

11.

Holtmann G, Talley N, Liebregts T, Adam B, Parow C . A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006; 354(8):832-40. DOI: 10.1056/NEJMoa052639. View

12.

St Sauver J, Grossardt B, Yawn B, Melton 3rd L, Pankratz J, Brue S . Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012; 41(6):1614-24. PMC: 3535751. DOI: 10.1093/ije/dys195. View

13.

Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T . Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010; 25(6):1151-6. DOI: 10.1111/j.1440-1746.2010.06249.x. View

14.

Koloski N, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley N . The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012; 61(9):1284-90. DOI: 10.1136/gutjnl-2011-300474. View

15.

Moshiree B, Price D, Robinson M, Gaible R, Verne G . Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain. 2007; 23(4):323-30. DOI: 10.1097/AJP.0b013e318032e496. View

16.

Posserud I, Agerforz P, Ekman R, Bjornsson E, Abrahamsson H, Simren M . Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut. 2004; 53(8):1102-8. PMC: 1774150. DOI: 10.1136/gut.2003.017962. View

17.

Locke 3rd G, Talley N, Fett S, Zinsmeister A, Melton 3rd L . Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997; 112(5):1448-56. DOI: 10.1016/s0016-5085(97)70025-8. View

18.

Halder S, Richard Locke 3rd G, Schleck C, Zinsmeister A, Melton 3rd L, Talley N . Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007; 133(3):799-807. DOI: 10.1053/j.gastro.2007.06.010. View

19.

Choung R, Locke 3rd G, Schleck C, Zinsmeister A, Talley N . Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities?. Neurogastroenterol Motil. 2011; 24(3):229-34, e106. PMC: 3589973. DOI: 10.1111/j.1365-2982.2011.01845.x. View

20.

Caldarella M, Giamberardino M, Sacco F, Affaitati G, Milano A, Lerza R . Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia. Am J Gastroenterol. 2007; 101(12):2782-9. DOI: 10.1111/j.1572-0241.2006.00823.x. View